Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD

P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD

US Patent 11291659 · Granted Apr 5, 2022

Estimated economic value: $32,956,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Antisense oligonucleotides targeting alpha-synuclein and uses thereof2025
Antisense oligonucleotides targeting alpha-synuclein and uses thereof2024
Macrocyclic azolopyridine derivatives as EED and PRC2 modulators2024
Macrocyclic azolopyridine derivatives as EED and PRC2 modulators2024
Tau-protein targeting compounds and associated2024
Methods of selecting therapeutic molecules2023
Macrocyclic azolopyridine derivatives as EED and PRC2 modulators2023
Macrocyclic azolopyridine derivatives as EED and PRC2 modulators2023
Use of p38 inhibitors to reduce expression of DUX42022
Use of p38 inhibitors to reduce expression of DUX42022
Use of p38 inhibitors to reduce expression of DUX42022
Use of p38 inhibitors to reduce expression of DUX42022